位置:首页 > 蛋白库 > PCNT_MOUSE
PCNT_MOUSE
ID   PCNT_MOUSE              Reviewed;        2898 AA.
AC   P48725; A0JBT0; A0JBT1;
DT   01-FEB-1996, integrated into UniProtKB/Swiss-Prot.
DT   20-APR-2010, sequence version 2.
DT   25-MAY-2022, entry version 149.
DE   RecName: Full=Pericentrin;
GN   Name=Pcnt; Synonyms=Pcnt2;
OS   Mus musculus (Mouse).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
OC   Eutheria; Euarchontoglires; Glires; Rodentia; Myomorpha; Muroidea; Muridae;
OC   Murinae; Mus; Mus.
OX   NCBI_TaxID=10090;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 3).
RX   PubMed=8124707; DOI=10.1016/0092-8674(94)90504-5;
RA   Doxsey S.J., Stein P., Evans L., Calarco P.D., Kirschner M.;
RT   "Pericentrin, a highly conserved centrosome protein involved in microtubule
RT   organization.";
RL   Cell 76:639-650(1994).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORMS 1 AND 2), TISSUE SPECIFICITY, AND
RP   DEVELOPMENTAL STAGE.
RC   TISSUE=Embryo;
RX   PubMed=17084386; DOI=10.1016/j.bbrc.2006.10.101;
RA   Miyoshi K., Asanuma M., Miyazaki I., Matsuzaki S., Tohyama M., Ogawa N.;
RT   "Characterization of pericentrin isoforms in vivo.";
RL   Biochem. Biophys. Res. Commun. 351:745-749(2006).
RN   [3]
RP   INTERACTION WITH CHD3 AND CHD4, SUBCELLULAR LOCATION, AND FUNCTION.
RX   PubMed=17626165; DOI=10.1091/mbc.e06-07-0604;
RA   Sillibourne J.E., Delaval B., Redick S., Sinha M., Doxsey S.J.;
RT   "Chromatin remodeling proteins interact with pericentrin to regulate
RT   centrosome integrity.";
RL   Mol. Biol. Cell 18:3667-3680(2007).
RN   [4]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-1437, AND IDENTIFICATION BY
RP   MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=19144319; DOI=10.1016/j.immuni.2008.11.006;
RA   Trost M., English L., Lemieux S., Courcelles M., Desjardins M.,
RA   Thibault P.;
RT   "The phagosomal proteome in interferon-gamma-activated macrophages.";
RL   Immunity 30:143-154(2009).
RN   [5]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-1437; SER-1859 AND SER-1860,
RP   AND IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Brown adipose tissue, Kidney, Liver, Pancreas, Spleen, and Testis;
RX   PubMed=21183079; DOI=10.1016/j.cell.2010.12.001;
RA   Huttlin E.L., Jedrychowski M.P., Elias J.E., Goswami T., Rad R.,
RA   Beausoleil S.A., Villen J., Haas W., Sowa M.E., Gygi S.P.;
RT   "A tissue-specific atlas of mouse protein phosphorylation and expression.";
RL   Cell 143:1174-1189(2010).
RN   [6]
RP   INTERACTION WITH CDK5RAP2, AND DEVELOPMENTAL STAGE.
RX   PubMed=20471352; DOI=10.1016/j.neuron.2010.03.036;
RA   Buchman J.J., Tseng H.C., Zhou Y., Frank C.L., Xie Z., Tsai L.H.;
RT   "Cdk5rap2 interacts with pericentrin to maintain the neural progenitor pool
RT   in the developing neocortex.";
RL   Neuron 66:386-402(2010).
CC   -!- FUNCTION: Integral component of the filamentous matrix of the
CC       centrosome involved in the initial establishment of organized
CC       microtubule arrays in both mitosis and meiosis. Plays a role, together
CC       with DISC1, in the microtubule network formation. Is an integral
CC       component of the pericentriolar material (PCM). May play an important
CC       role in preventing premature centrosome splitting during interphase by
CC       inhibiting NEK2 kinase activity at the centrosome.
CC       {ECO:0000250|UniProtKB:O95613, ECO:0000269|PubMed:17626165}.
CC   -!- SUBUNIT: Interacts with DISC1 and PCM1. Binds calmodulin. Interacts
CC       with CEP131 (By similarity). Interacts with CDK5RAP2; the interaction
CC       is leading to centrosomal localization of PCNT and CDK5RAP2
CC       (PubMed:20471352). Interacts with CHD3 (PubMed:17626165). Interacts
CC       with CHD4; the interaction regulates centrosome integrity
CC       (PubMed:17626165). Interacts with NEK2 (By similarity). Interacts with
CC       CCDC13 (By similarity). Interacts with CEP68 (By similarity). Interacts
CC       with ATF5; the ATF5:PCNT:polyglutamylated tubulin (PGT) tripartite
CC       unites the mother centriole and the pericentriolar material (PCM) in
CC       the centrosome (By similarity). {ECO:0000250|UniProtKB:O95613,
CC       ECO:0000269|PubMed:17626165, ECO:0000269|PubMed:20471352}.
CC   -!- INTERACTION:
CC       P48725; Q6A078: Cep290; NbExp=2; IntAct=EBI-2290976, EBI-1811999;
CC   -!- SUBCELLULAR LOCATION: Cytoplasm, cytoskeleton, microtubule organizing
CC       center, centrosome {ECO:0000250|UniProtKB:O95613}. Note=Centrosomal at
CC       all stages of the cell cycle. Remains associated with centrosomes
CC       following microtubule depolymerization. Colocalized with DISC1 at the
CC       centrosome. {ECO:0000250|UniProtKB:O95613}.
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative splicing; Named isoforms=3;
CC       Name=1; Synonyms=Pericentrin B, Pericentrin-360;
CC         IsoId=P48725-1; Sequence=Displayed;
CC       Name=2; Synonyms=Pericentrin S, Pericentrin-255;
CC         IsoId=P48725-2; Sequence=VSP_038927;
CC       Name=3;
CC         IsoId=P48725-3; Sequence=VSP_038928, VSP_038929;
CC   -!- TISSUE SPECIFICITY: Expressed in heart and lung (at protein level).
CC       Expressed in kidney, thymus, liver, brain, muscle, testis, spleen, lung
CC       and heart. {ECO:0000269|PubMed:17084386}.
CC   -!- DEVELOPMENTAL STAGE: Expressed in embryo at 17 dpc (at protein level).
CC       Expressed in embryos at 7, 11, 15 and 17 dpc. Strongly expressed in
CC       brain tissues at early stages of development.
CC       {ECO:0000269|PubMed:17084386, ECO:0000269|PubMed:20471352}.
CC   -!- DOMAIN: Composed of a coiled-coil central region flanked by non-helical
CC       N- and C-terminals.
CC   -!- PTM: Cleaved during mitotis which leads to removal of CDK5RAP2 from the
CC       centrosome and promotes centriole disengagement and subsequent
CC       centriole separation. The C-terminal fragment is rapidly degraded
CC       following cleavage. {ECO:0000250|UniProtKB:O95613}.
CC   -!- SEQUENCE CAUTION:
CC       Sequence=AAA17886.1; Type=Erroneous termination; Note=Truncated C-terminus.; Evidence={ECO:0000305};
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; U05823; AAA17886.1; ALT_SEQ; mRNA.
DR   EMBL; AB207233; BAF36559.1; -; mRNA.
DR   EMBL; AB207234; BAF36560.1; -; mRNA.
DR   CCDS; CCDS88027.1; -. [P48725-1]
DR   PIR; A53188; A53188.
DR   RefSeq; NP_001269921.1; NM_001282992.1.
DR   RefSeq; NP_032813.3; NM_008787.3.
DR   SMR; P48725; -.
DR   BioGRID; 202052; 8.
DR   CORUM; P48725; -.
DR   IntAct; P48725; 3.
DR   STRING; 10090.ENSMUSP00000001179; -.
DR   iPTMnet; P48725; -.
DR   PhosphoSitePlus; P48725; -.
DR   EPD; P48725; -.
DR   jPOST; P48725; -.
DR   MaxQB; P48725; -.
DR   PaxDb; P48725; -.
DR   PeptideAtlas; P48725; -.
DR   PRIDE; P48725; -.
DR   ProteomicsDB; 287893; -. [P48725-1]
DR   ProteomicsDB; 287894; -. [P48725-2]
DR   ProteomicsDB; 287895; -. [P48725-3]
DR   GeneID; 18541; -.
DR   KEGG; mmu:18541; -.
DR   UCSC; uc007fuj.1; mouse. [P48725-1]
DR   CTD; 5116; -.
DR   MGI; MGI:102722; Pcnt.
DR   eggNOG; ENOG502QV16; Eukaryota.
DR   InParanoid; P48725; -.
DR   OrthoDB; 8180at2759; -.
DR   PhylomeDB; P48725; -.
DR   Reactome; R-MMU-2565942; Regulation of PLK1 Activity at G2/M Transition.
DR   Reactome; R-MMU-380259; Loss of Nlp from mitotic centrosomes.
DR   Reactome; R-MMU-380270; Recruitment of mitotic centrosome proteins and complexes.
DR   Reactome; R-MMU-380284; Loss of proteins required for interphase microtubule organization from the centrosome.
DR   Reactome; R-MMU-380320; Recruitment of NuMA to mitotic centrosomes.
DR   Reactome; R-MMU-5620912; Anchoring of the basal body to the plasma membrane.
DR   Reactome; R-MMU-8854518; AURKA Activation by TPX2.
DR   Reactome; R-MMU-9646399; Aggrephagy.
DR   BioGRID-ORCS; 18541; 13 hits in 71 CRISPR screens.
DR   ChiTaRS; Pcnt; mouse.
DR   PRO; PR:P48725; -.
DR   Proteomes; UP000000589; Unplaced.
DR   RNAct; P48725; protein.
DR   GO; GO:0034451; C:centriolar satellite; ISS:UniProtKB.
DR   GO; GO:0005814; C:centriole; IDA:MGI.
DR   GO; GO:0005813; C:centrosome; IDA:MGI.
DR   GO; GO:0036064; C:ciliary basal body; IDA:MGI.
DR   GO; GO:0005929; C:cilium; TAS:Reactome.
DR   GO; GO:0005801; C:cis-Golgi network; IDA:MGI.
DR   GO; GO:0005829; C:cytosol; ISO:MGI.
DR   GO; GO:0045171; C:intercellular bridge; IDA:MGI.
DR   GO; GO:0005874; C:microtubule; IEA:UniProtKB-KW.
DR   GO; GO:0005815; C:microtubule organizing center; IDA:MGI.
DR   GO; GO:0031514; C:motile cilium; IDA:MGI.
DR   GO; GO:0000242; C:pericentriolar material; IDA:MGI.
DR   GO; GO:0005516; F:calmodulin binding; IEA:UniProtKB-KW.
DR   GO; GO:0060090; F:molecular adaptor activity; IEA:InterPro.
DR   GO; GO:0048854; P:brain morphogenesis; IMP:MGI.
DR   GO; GO:0043010; P:camera-type eye development; IMP:MGI.
DR   GO; GO:0021696; P:cerebellar cortex morphogenesis; IMP:MGI.
DR   GO; GO:0060271; P:cilium assembly; ISO:MGI.
DR   GO; GO:1990403; P:embryonic brain development; IMP:MGI.
DR   GO; GO:0035050; P:embryonic heart tube development; IMP:MGI.
DR   GO; GO:0060322; P:head development; IMP:MGI.
DR   GO; GO:0001701; P:in utero embryonic development; IMP:MGI.
DR   GO; GO:0001822; P:kidney development; IMP:MGI.
DR   GO; GO:0035108; P:limb morphogenesis; IMP:MGI.
DR   GO; GO:0000226; P:microtubule cytoskeleton organization; ISS:UniProtKB.
DR   GO; GO:0007052; P:mitotic spindle organization; IMP:MGI.
DR   GO; GO:0035264; P:multicellular organism growth; IMP:MGI.
DR   GO; GO:0043066; P:negative regulation of apoptotic process; IMP:MGI.
DR   GO; GO:0061351; P:neural precursor cell proliferation; IMP:MGI.
DR   GO; GO:0001764; P:neuron migration; IMP:MGI.
DR   GO; GO:0021772; P:olfactory bulb development; IMP:MGI.
DR   GO; GO:0090316; P:positive regulation of intracellular protein transport; ISS:UniProtKB.
DR   GO; GO:0007165; P:signal transduction; IEA:InterPro.
DR   GO; GO:0007051; P:spindle organization; IDA:MGI.
DR   GO; GO:0001944; P:vasculature development; IMP:MGI.
DR   InterPro; IPR028745; AKAP9/Pericentrin.
DR   InterPro; IPR019528; PACT_domain.
DR   PANTHER; PTHR44981; PTHR44981; 3.
DR   Pfam; PF10495; PACT_coil_coil; 1.
PE   1: Evidence at protein level;
KW   Alternative splicing; Calmodulin-binding; Coiled coil; Cytoplasm;
KW   Cytoskeleton; Microtubule; Phosphoprotein; Reference proteome.
FT   CHAIN           1..2898
FT                   /note="Pericentrin"
FT                   /id="PRO_0000058258"
FT   REGION          1..117
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   REGION          429..460
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   REGION          1745..1786
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   REGION          1801..1822
FT                   /note="Interaction with CDK5RAP2"
FT                   /evidence="ECO:0000269|PubMed:20471352"
FT   REGION          1815..1880
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   REGION          1958..1979
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   REGION          2046..2088
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   REGION          2509..2532
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   REGION          2545..2810
FT                   /note="Interaction with NEK2"
FT                   /evidence="ECO:0000250"
FT   REGION          2653..2684
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   REGION          2758..2771
FT                   /note="Calmodulin-binding"
FT                   /evidence="ECO:0000250"
FT   REGION          2787..2898
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COILED          127..343
FT                   /evidence="ECO:0000255"
FT   COILED          382..434
FT                   /evidence="ECO:0000255"
FT   COILED          468..527
FT                   /evidence="ECO:0000255"
FT   COILED          611..696
FT                   /evidence="ECO:0000255"
FT   COILED          727..787
FT                   /evidence="ECO:0000255"
FT   COILED          872..939
FT                   /evidence="ECO:0000255"
FT   COILED          1069..1383
FT                   /evidence="ECO:0000255"
FT   COILED          1429..1482
FT                   /evidence="ECO:0000255"
FT   COILED          1529..1593
FT                   /evidence="ECO:0000255"
FT   COILED          2211..2403
FT                   /evidence="ECO:0000255"
FT   COILED          2429..2590
FT                   /evidence="ECO:0000255"
FT   COMPBIAS        1..37
FT                   /note="Basic and acidic residues"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        51..85
FT                   /note="Polar residues"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        98..114
FT                   /note="Polar residues"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        1748..1770
FT                   /note="Polar residues"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        1815..1835
FT                   /note="Polar residues"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        2653..2667
FT                   /note="Polar residues"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        2803..2828
FT                   /note="Polar residues"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        2839..2864
FT                   /note="Polar residues"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   MOD_RES         44
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000250|UniProtKB:O95613"
FT   MOD_RES         1022
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000250|UniProtKB:O95613"
FT   MOD_RES         1437
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0007744|PubMed:19144319,
FT                   ECO:0007744|PubMed:21183079"
FT   MOD_RES         1828
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000250|UniProtKB:O95613"
FT   MOD_RES         1859
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0007744|PubMed:21183079"
FT   MOD_RES         1860
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0007744|PubMed:21183079"
FT   MOD_RES         1959
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000250|UniProtKB:O95613"
FT   MOD_RES         1987
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000250|UniProtKB:O95613"
FT   MOD_RES         2128
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000250|UniProtKB:O95613"
FT   MOD_RES         2865
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000250|UniProtKB:O95613"
FT   VAR_SEQ         1..916
FT                   /note="Missing (in isoform 2)"
FT                   /evidence="ECO:0000303|PubMed:17084386"
FT                   /id="VSP_038927"
FT   VAR_SEQ         2044..2050
FT                   /note="ALSESQD -> GNSRLLF (in isoform 3)"
FT                   /evidence="ECO:0000303|PubMed:8124707"
FT                   /id="VSP_038928"
FT   VAR_SEQ         2501..2898
FT                   /note="Missing (in isoform 3)"
FT                   /evidence="ECO:0000303|PubMed:8124707"
FT                   /id="VSP_038929"
FT   CONFLICT        652
FT                   /note="Missing (in Ref. 1; AAA17886)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        662
FT                   /note="Missing (in Ref. 1; AAA17886)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        896..897
FT                   /note="EL -> DV (in Ref. 1; AAA17886)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        960
FT                   /note="R -> G (in Ref. 1; AAA17886)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        982
FT                   /note="A -> P (in Ref. 1; AAA17886)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        1022
FT                   /note="S -> R (in Ref. 1; AAA17886)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        1150
FT                   /note="Q -> E (in Ref. 1; AAA17886)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        1266..1267
FT                   /note="EH -> DD (in Ref. 1; AAA17886)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        1533
FT                   /note="N -> D (in Ref. 1; AAA17886)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        1548
FT                   /note="R -> G (in Ref. 1; AAA17886)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        1726
FT                   /note="N -> G (in Ref. 1; AAA17886)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        1736
FT                   /note="E -> Q (in Ref. 1; AAA17886)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        1772
FT                   /note="C -> S (in Ref. 1; AAA17886)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        2040
FT                   /note="H -> L (in Ref. 1; AAA17886)"
FT                   /evidence="ECO:0000305"
SQ   SEQUENCE   2898 AA;  329465 MW;  50E66D93F7E4E283 CRC64;
     MEDEQEQRRR KVEAGRAKLA NFRQRKTKGD CPNSKKKTAK RKGSAVHASV QEEGSVATPN
     SELPQGGAVF ESPSCSNTLE GTRGASAAQE QEDCELDVTD LQGQQQTQPP PPQTAHSLEL
     EALRLSLNNM HTAQLELTQA NLQKEKETAL TELREMLNGR RAQELALLQS RQQCELELLR
     EQHAREKEEM ALRSGQEAAE LKEKLRSEME KNAQTIETLK QDWESERELC LENLRQELSL
     KHQSEMEGLQ SQFQKELSEQ KVELEKIFQA KHEAEVSLKN LEAQHQAAIK KLQEDLQSEH
     CQYLQDLEQK FREKEKAKEL ELETLQASYE DLKAQSQEEI RLLWSQLESM KTNREELNGS
     WDPVLAQASH LEELEHLRSG FAQQQQQERA QHESELEHLR VYFEKKLKDA EKTYQEDLTV
     FQQRLQEARE DSLESTEISS SCVLPEETSG REGKEPPDPL DLQLGQPKVQ ESLVEDCQVK
     LSKAEEKIQQ MKEEFQKKEA EWELSREELK REAEERLASM FLELREKAES EKLSIISRFE
     HRESSMRHLQ DQQAAQILDL ERSLMEQQGH LRQLEQELTR DDLLPCSQCG QEPAMAQEEK
     NGALLREKED CALQLLMAQN RFLEERKEIM EKFAKEQDAF LRDAQEKHNH ELQLLQQGHQ
     QQLLALRMEL ETKHRSELTE QLASSESRRQ ALLETHVAEL QVKHNAEISA LEKRHLSNLD
     ELESCYVADV QTIRDEHQQA LELLRAELEE QLQKKESCHR EMLTQELENL KRQHAEELQS
     VRDSLRMEMS AQHIENGKGP AADLQGAHQQ DPAMALHNEG HLLVEDGDAV LRSVDAEGLL
     HQAGPQELGD AHTVEMQKSQ AELAKPQELQ ASQDQVAQVR DKVFLLNREL EECRAELEQL
     QQRRERENQE GTTLICMLRA DLELAQGEGK ALRDALRRLL DLFGDTLKAA VTLKSRISER
     AGLLLDHEDA ADTSDARLAA AALGDMWSDE GLLEIDRTLP EGAETSSVCE ISSHVCESFF
     ISPENTLDCE QPIRRVYQSL STAVEGLLEM ALDSSKQLEE ARQLHRCVER EFRHRNEEMA
     QAMQKQQELL ERLREESAAK DRLALELHTA KGLLEGFKVE KVDLQEALGK KEESEQQLIL
     ELEDLRKQLQ QAARELLTLK EEKSVLWNQK ETLTNEAKER EAALQEEVES LTRVQWESRK
     QSEKDRATLL SQMRVLESEL EDQLVQHRGC AQLAEEVATL KQQLAALDKH LRSQRQFMDD
     QAAEREHERE EFQQEIQRLE GQLRQAARPR PPGPRDSQCV QLDEEVELLQ EKLREKLDGF
     NELVIKKDFA DQQLLIQEEE IKRLEETNAS IQRQMVQLQE ELEKQKKSME ELKEKEILKQ
     ENMGDLLLTT VSRSGLDEAG CPMLPQGSSS RGPEAQPDVT ERALLQHENE VVHRRNSEID
     ELKSLIENLQ ENQRQLQKDK AEEIEQLHEV IEKLQSELSL MGPKVHEVSD PQAGSLHSEL
     ACLRGEGLGG QALRSELQAA QAAKEVFGQL LANQAHGHSQ ALEALQQRLQ DAEEVAARHL
     AELEHCVALR EAEVEAMASQ IQEFAATLKA KEAIIEQRDL EIDAVNKWKV SHSLELEAIL
     LALAHFRHAL EQQTCATPDE PPELRQLRVQ CARLSHQLQV LYRPFLKCRM QLDQHQPHVA
     SIGCANPCAD DELEQEGVSN RLALAPHSLA AQAKEELEDC PLGKANLMAQ VRQLQEELDH
     RVHSVASRDT NSETCKLQQP NLSENGPRNH CCNGEESKPS PPDDVLNIAK TTWDVIDIIK
     NQDLLVQVEM PDFPTQEKLT SQGGPFSSQA SGHSGSLLPE EAAEPQQDPV RALDLSSWSS
     PEVVRKDPSL EPQHSLPLTP GVGTVSLHSV DISPDWTDPL LQADVSGLLC YPGKSASGQA
     PLWAVAPSAG KHHAERTATE KDVEDFIVTS FDSQELLTSP SHELARRSDG SRKSDGPDIA
     MMLTLGSEGS ETPTTDLVAA AAAAVPFSRR FVQSPGAMKE KEIHAKQMKA LLQMVFDESH
     QILALSESQD PSSALNKGEP RDPLDGFPRD SQALSEVTTD KGEKESLETH LTWSEELLRA
     IQEVFAREQE KAELQPRPYG SNLGDYNSLV QRLEKVIQEQ GDPQKVQDHL CLSDRSSLLA
     EIQALRAQLR MTHLQNQEKL QQLCAALTST EARGSQREHQ LRRQVELLAY KVEQEKCIAN
     ELQKTLSKEQ ETASDVRKRL VVEQNAVQDL KSELHACKQE NTSLLESLDK VQQEVLRLRA
     VLDGKEKELK VVLEELESER GKGQALQAQQ EEQQLRYLQR EGQSSRALEE LKLSLEKQLA
     QNNQLCVALK HERAAKDNLQ KELQIEASRC EALLAQEKGQ LSELQKSLEA ERSRSLELSE
     ALQHERLLTE QLSRNSQEAC ARQETQVQHA LLRKLKAEKT RALELEAMLE KVQKQAAHTQ
     QQLEAQAQER CVELRREKER ELEIQRQRDE HKIEQLQRLV RELRWKEEVS GGNGPCRGSP
     GRGSLERDQF QEQQQELEKI RQQLLCAAGL LTSFTNHTVD RTIKDWTSSN EKAVSSLMRT
     LEELKSELSM PTSFQKKMTA ELQVQLMNEL LSDNDALTKA VGMATREKAE LCRTVSRLEK
     TLKHHTQKGC VLNRQSKSSL KQDGTDLQSS LRHSDPEWHS QTTSGDTNTC NIKMEKLYLH
     YLRAESFRKA LIYQKKYLLL LIGGFQDSEQ ETLSMIAHLG VFPSKADKKI TMSRPFTKFR
     TAVRVVIAVL RLRFLVKKWQ EVDRKGALVH PKSTRHGHRT SQRQRSPSGP RASLPTRDTS
     SGPTKASRHS PRSAAAGSPG KERSTSTPSS RLERSLTASQ DPEHSLTEYI HHLEMIQQRL
     GGLPPDSTQK SCHQKIKQ
 
 
维奥蛋白资源库 - 中文蛋白资源 CopyRight © 2010-2024